ROSEN Law Firm Encourages Boston Scientific Investors to Secure Counsel Before Deadline

Lawsuit alleges Boston Scientific misled investors about growth in its U.S. Electrophysiology segment

Published on Mar. 7, 2026

Got story updates? Submit your updates here. ›

The ROSEN Law Firm, a global investor rights law firm, has announced a class action lawsuit on behalf of purchasers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026. The lawsuit alleges that Boston Scientific made positive statements to investors while disseminating materially false and misleading information about the true state of its U.S. Electrophysiology segment, leading to investor losses when the truth came to light.

Why it matters

This case highlights the importance of transparency and accurate disclosures from public companies, as investors rely on this information to make informed decisions. The lawsuit seeks to recover damages for Boston Scientific investors who may have been misled by the company's statements.

The details

According to the lawsuit, Boston Scientific's management was aware that the growth rate of its U.S. Electrophysiology segment was unsustainable and approaching an earlier tipping point than the market anticipated. However, the company allegedly made positive statements to investors while concealing this material information. As a result, investors and analysts were surprised when Boston Scientific reported a net income miss and underwhelming guidance for the first half of fiscal 2026.

  • The class period is from July 23, 2025 to February 3, 2026.
  • Investors must move the Court no later than May 4, 2026 to serve as lead plaintiff.

The players

Boston Scientific Corporation

A medical device company that develops, manufactures, and markets medical devices for use in various interventional medical specialties.

ROSEN Law Firm

A global investor rights law firm that represents investors throughout the world, concentrating its practice in securities class actions and shareholder derivative litigation.

Got photos? Submit your photos here. ›

What they’re saying

“To join the Boston Scientific class action, go to https://rosenlegal.com/submit-form/?case_id=55398 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.”

— Phillip Kim, Esq. (ROSEN Law Firm)

What’s next

Investors must move the Court no later than May 4, 2026 to serve as lead plaintiff in the class action lawsuit.

The takeaway

This case highlights the importance of transparency and accurate disclosures from public companies, as investors rely on this information to make informed decisions. The ROSEN Law Firm is encouraging Boston Scientific investors to secure counsel before the important deadline to potentially recover damages.